
Sign up to save your podcasts
Or


GLP-1 therapies reduce cardiovascular events, likely through visceral adipose tissue reduction, reframing cardiology treatment toward upstream metabolic disease targeting
Read post
Visceral fat sits silently behind heart disease, dementia, prediabetes, joint pain and aggressive prostate cancer risk
Read post
Fructose quietly drives visceral fat, insulin resistance, and small dense LDL, reshaping cardiovascular risk within today’s ultra-processed food environment modern.
Read post
Two patients. Same LDL. One needs a statin. The other needs a tape measure. Here's how to tell which one you are.
Read post
Simple grip strength testing predicts heart disease better than blood pressure. Two three-minute muscle function tests reveal your metabolic resilience and can be tracked at home monthly. Strong muscles actively fight visceral fat accumulation across all cardiovascular risk factors.
Read post
In cardiometabolic medicine, muscle is not a cosmetic tissue but a metabolic organ. Evidence consistently shows that strength, not muscle mass, predicts insulin resistance, cardiovascular risk, and survival. Many older adults are not losing muscle tissue — they are losing muscle function, and that is the pathology that matters.
Read Blog
The Eight-Month Metabolic Reset is a structured cardiometabolic programme designed to reduce visceral fat, preserve skeletal muscle strength, and improve glucose stability. Combining lifestyle change, targeted metabolic support, and clinical guidance, it helps break the cardiometabolic cycle and build sustainable long-term health beyond short-term weight loss.
Read the blog
Prediabetes should be viewed as an active cardiometabolic disease stage rather than a passive risk marker. Cardiovascular injury begins before overt diabetes, creating a critical window for intervention. Lifestyle therapy remains fundamental, while agents such as metformin, GLP-1 receptor agonists, dual incretin therapies, and SGLT2 inhibitors may help modify long-term cardiovascular risk.
https://www.scvc.co.uk/vat/glucose-insulin-dynamics/prediabetes-as-a-therapeutic-target-a-cardiologists-editorial-perspective/
Because cholesterol is a fat-like substance, it cannot dissolve or travel freely in blood, which is mostly water. To move around, it must be packaged into microscopic transport particles called lipoproteins. One of these, LDL (low-density lipoprotein), acts as the main delivery vehicle, carrying cholesterol from the liver to cells that need it for repair or hormone production. In small amounts, LDL cholesterol is therefore completely normal and necessary. The problem only begins when too much LDL remains circulating in the blood for too long.
For more details see the blog article https://www.scvc.co.uk/vat-trap/pcsk9-visceral-fat-and-the-modern-metabolic-environment/
Porridge is healthy — but adding cream may improve its metabolic impact. This cardiologist explains how moderating glucose spikes, protecting muscle and reducing small dense LDL formation can support cardiovascular health, particularly in patients with visceral adiposity and insulin resistance.
To read more see
https://www.scvc.co.uk/metabolic-health-weight/why-a-cardiologist-puts-cream-on-his-porridge/
To review all podcasts is series https://feeds.transistor.fm/vat-trap
From the publisher's feed